搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Synechococcus sp. Putative Holliday junction resolvase (Syncc9902_0783) CSB-YP658890SBAD
CSB-EP658890SBAD
CSB-BP658890SBAD
CSB-MP658890SBAD
CSB-EP658890SBAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Cysteine--tRNA ligase (cysS) CSB-YP658891SBAD
CSB-EP658891SBAD
CSB-BP658891SBAD
CSB-MP658891SBAD
CSB-EP658891SBAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Ribosomal RNA small subunit methyltransferase G (rsmG) CSB-YP658892SBAD
CSB-EP658892SBAD
CSB-BP658892SBAD
CSB-MP658892SBAD
CSB-EP658892SBAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Translation initiation factor IF-2 (infB), partial CSB-YP658893SBAD
CSB-EP658893SBAD
CSB-BP658893SBAD
CSB-MP658893SBAD
CSB-EP658893SBAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Probable transcriptional regulatory protein Syncc9902_0542 (Syncc9902_0542) CSB-YP658894SBAD
CSB-EP658894SBAD
CSB-BP658894SBAD
CSB-MP658894SBAD
CSB-EP658894SBAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. ATP synthase epsilon chain (atpC) CSB-YP658895SBAD
CSB-EP658895SBAD
CSB-BP658895SBAD
CSB-MP658895SBAD
CSB-EP658895SBAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. ATP synthase subunit c (atpE), partial CSB-YP658896SBAD1
CSB-EP658896SBAD1
CSB-BP658896SBAD1
CSB-MP658896SBAD1
CSB-EP658896SBAD1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Photosystem II 12 kDa extrinsic protein (psbU) CSB-YP658897SBAD
CSB-EP658897SBAD
CSB-BP658897SBAD
CSB-MP658897SBAD
CSB-EP658897SBAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Photosystem I assembly protein ycf3 (ycf3) CSB-YP658898SBAD
CSB-EP658898SBAD
CSB-BP658898SBAD
CSB-MP658898SBAD
CSB-EP658898SBAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Queuine tRNA-ribosyltransferase (tgt) CSB-YP658899SBAD
CSB-EP658899SBAD
CSB-BP658899SBAD
CSB-MP658899SBAD
CSB-EP658899SBAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Photosystem II reaction center protein L (psbL), partial CSB-YP658900SBAD
CSB-EP658900SBAD
CSB-BP658900SBAD
CSB-MP658900SBAD
CSB-EP658900SBAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Holliday junction ATP-dependent DNA helicase RuvB (ruvB) CSB-YP658901SBAD
CSB-EP658901SBAD
CSB-BP658901SBAD
CSB-MP658901SBAD
CSB-EP658901SBAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. DNA mismatch repair protein MutS (mutS), partial CSB-YP658902SBAD
CSB-EP658902SBAD
CSB-BP658902SBAD
CSB-MP658902SBAD
CSB-EP658902SBAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. GMP synthase [glutamine-hydrolyzing] (guaA), partial CSB-YP658903SBAD
CSB-EP658903SBAD
CSB-BP658903SBAD
CSB-MP658903SBAD
CSB-EP658903SBAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pelodictyon luteolum Membrane protein insertase YidC (yidC), partial CSB-YP658904PAAP1
CSB-EP658904PAAP1
CSB-BP658904PAAP1
CSB-MP658904PAAP1
CSB-EP658904PAAP1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pelodictyon luteolum ATP synthase subunit a 2 (atpB2), partial CSB-YP658905PAAP1
CSB-EP658905PAAP1
CSB-BP658905PAAP1
CSB-MP658905PAAP1
CSB-EP658905PAAP1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pelodictyon luteolum Glycerol-3-phosphate acyltransferase (plsY), partial CSB-YP658906PAAP1
CSB-EP658906PAAP1
CSB-BP658906PAAP1
CSB-MP658906PAAP1
CSB-EP658906PAAP1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pelodictyon luteolum Probable potassium transport system protein kup (kup), partial CSB-YP658907PAAP
CSB-EP658907PAAP
CSB-BP658907PAAP
CSB-MP658907PAAP
CSB-EP658907PAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pelodictyon luteolum 50S ribosomal protein L11 (rplK) CSB-YP658908PAAP
CSB-EP658908PAAP
CSB-BP658908PAAP
CSB-MP658908PAAP
CSB-EP658908PAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pelodictyon luteolum Protein-L-isoaspartate O-methyltransferase (pcm) CSB-YP658909PAAP
CSB-EP658909PAAP
CSB-BP658909PAAP
CSB-MP658909PAAP
CSB-EP658909PAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>